388 results

• Ozempic and Mounjaro Drug Class Linked to 35% Higher NAION Vision Loss Risk

  May 14, 2026

  Irvin Jackson

  New research provides further evidence that Ozempic and similar drugs can increase the risk of a rare, but often permanent, form of vision loss.

• Intracranial Meningioma from Depo-Provera Shots Caused Hearing Loss, Vision Loss: Lawsuit

  May 12, 2026

  Irvin Jackson

  A Depo-Provera intracranial meningioma lawsuit claims Pfizer developed and sold a defective birth control injection that puts women at a five times increased risk of brain tumors.

• Ozempic Vision Loss Lawsuit Highlights Devastating Consequences of NAION Diagnosis

  May 4, 2026

  Irvin Jackson

  A Massachusetts man has filed an Ozempic vision loss lawsuit claiming the diabetes drug injections caused a condition that eroded his vision in both eyes.

• Lawsuit Claims Ryobi Pressure Washer Explosion Resulted in Severe Eye Injury

  May 4, 2026

  Martha Garcia

  A man who suffered a severe eye injury after his Ryobi pressure washer exploded has filed a lawsuit claiming the device was defectively designed.

• Thermos Recall Issued After Three Reports of Vision Loss From Stoppers Being Forcefully Ejected

  May 1, 2026

  Darian Hauf

  Federal regulators are recalling more than 8 million Thermos containers after reports that pressure buildup can cause defective stoppers to eject, posing impact and laceration injury risks.

• Lawsuit Blames Depo Shot for Brain Tumors, Intense Headaches

  April 28, 2026

  Irvin Jackson

  A Depo-Provera lawsuit filed against Pfizer says the manufacturer knew Depo-Provera could stimulate brain tumor growth before the birth control shots hit the market, yet failed to warn doctors and patients.

• GLP-1 Dementia, Alzheimer’s Disease Risks Questioned in New Study

  April 27, 2026

  Irvin Jackson

  A new study finds cognitive decline in patients taking GLP-1 medications for longer than 10 years, yet researchers say it may be the result of those patients living longer than their peers.

• GLP-1 Wrongful Death Lawsuit Claims Compounder Sold Contaminated Meds

  April 15, 2026

  Irvin Jackson

  The family of a Texas woman who died from an alleged GLP-1 overdose after using a drug sold by a compounding pharmacy has filed a class action lawsuit, claiming the medication was defectively formulated and unreasonably dangerous.

• Gastrointestinal Problems Are Most Common GLP-1 Side Effects, Study Finds

  April 6, 2026

  Irvin Jackson

  A new study links GLP-1 medications to increased gastrointestinal risks, while also raising broader concerns about other potential complications associated with the diabetes and weight loss drugs.

• Info on Link Between Ozempic and Vision Loss Will Be Presented During ‘Science Day’ in June 2026

  March 18, 2026

  Irvin Jackson

  A federal judge has called for an Ozempic and Wegovy vision loss lawsuit Science Day in June, to help the court understand the science behind NAION injury claims.